Skip to Content

ReproSTAR L5 HB

This page contains information on ReproSTAR L5 HB for veterinary use.
The information provided typically includes the following:
  • ReproSTAR L5 HB Indications
  • Warnings and cautions for ReproSTAR L5 HB
  • Direction and dosage information for ReproSTAR L5 HB

ReproSTAR L5 HB

This treatment applies to the following species:
Company: Elanco (Farm Animal)

Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For Use In Animals Only

ReproSTAR L5 HB Indications

This product has been shown to be effective for the vaccination of healthy cattle against Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae and pomona. The product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity for L. hardjo-bovis is at least 12 months and is unknown for the other serovars. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

The product has been shown to be effective against kidney colonization, urinary shedding, and reproductive tract infection caused by L. hardjo-bovis. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure.

ADJUVANT: Xtend™ SP.

Directions For Use

Shake well before using. Administer 2 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Repeat in 4 to 6 weeks. Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency, consultation with a veterinarian is recommended.

Precautions

Store out of direct sunlight at 2 to 8°C (35 to 46°F). DO NOT FREEZE. This product has not been tested in pregnant animals. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Milk reduction and transient depression may be observed in lactating dairy cows for 3 to 6 days following vaccination. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains thimerosal as a preservative.

VLN / PCN: 196 / 2665.07

Elanco US, Inc., Fort Dodge, IA 50501 USA; 1-800-428-4441

ReproSTAR, Xtend, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

10 Doses

20 mL

YL102741A

50 Doses

100 mL

YL102741B

CPN: 1114108.4

ELANCO US, INC.
Distributed by ELANCO US, INC.
2500 INNOVATION WAY, GREENFIELD, IN, 46140
Customer Service:   317-276-1262
Technical Service:   800-428-4441
Website:   www.elanco.us
Email:   elanco@elanco.com
Every effort has been made to ensure the accuracy of the ReproSTAR L5 HB information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2021 Animalytix LLC. Updated: 2020-12-31